Interaction of calcium antagonists with beta-adrenoceptor blocking agents

Area of Science:

• Cardiovascular Pharmacology
• Cardiac Electrophysiology

Background:

• Beta-adrenoceptor blockers and calcium antagonists are commonly prescribed cardiovascular drugs.
• Interactions between these drug classes can affect cardiac function.
• Verapamil is a well-studied calcium antagonist with known electrophysiological and mechanical effects.

Purpose of the Study:

• To investigate the impact of chronic beta-adrenoceptor blockade on cardiac responsiveness to verapamil.
• To compare the effects of propranolol versus oxprenolol (a beta-blocker with intrinsic sympathomimetic activity) on verapamil's cardiac actions.

Main Methods:

• Rabbits were pretreated with propranolol or oxprenolol for one or six weeks.
• Cardiac tissues were isolated and exposed to verapamil, diltiazem, or fendiline.
• Electrical and mechanical responses, including contractility and conduction times, were measured.

Main Results:

• Short-term (one week) beta-blockade did not significantly alter responses to verapamil.
• Long-term (six weeks) propranolol pretreatment aggravated verapamil's negative inotropic effects and conduction delays.
• Long-term oxprenolol pretreatment did not significantly alter verapamil's cardiac effects.

Conclusions:

• Prolonged oxprenolol administration shows fewer adverse cardiac interactions with verapamil compared to propranolol.
• Concomitant use of verapamil with beta-blockers possessing intrinsic sympathomimetic activity may be safer during chronic blockade.